Viewing Study NCT04426968


Ignite Creation Date: 2025-12-24 @ 5:38 PM
Ignite Modification Date: 2025-12-25 @ 3:09 PM
Study NCT ID: NCT04426968
Status: COMPLETED
Last Update Posted: 2025-01-27
First Post: 2020-06-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
Sponsor: Shanghai HEP Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module